MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Assessing the Impact of Deep Brain Stimulation on Cognitive Impairment in Parkinson’s Disease: a longitudinal study.

    K. Velázquez-Román, G. Rivera-Monroy, R. Baños-Betancourt, W. Moguel-Cardín, A. Guerra-Anzaldo, C. álvarez-Hernández, A. Domínguez-García, A. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico city, Mexico)

    Objective: To longitudinally assess cognitive function post-DBS in Patients with Parkinson's Disease. Background: Parkinson's disease (PD) is a chronic neurodegenerative condition that primarily affects the…
  • 2024 International Congress

    Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson’s disease: results from a phase II randomised control trial (STRIPE)

    M. Smith, A. Cullen, G. Portlock, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To undertake a randomised control trial of transcutaneous tibial nerve stimulation (TTNS) delivered by Geko™ device for LUTS related to overactive bladder (OAB) symptoms…
  • 2024 International Congress

    Association Between Motor Symptoms and Autonomic Dysfunction in De Novo Parkinson’s Disease: Insights into the Role of the Gut-Brain Axis

    KY. Kwon, JE. Park (Seoul, Republic of Korea)

    Objective: This retrospective study aimed to investigate the relationship between motor symptoms and autonomic dysfunction in patients with de novo Parkinson's disease(PD). Background: Dysautonomia in…
  • 2024 International Congress

    Prodromal Parkinson’s disease in the general population

    G. de Klerk, T. van Laar, S. Meles (Groningen, Netherlands)

    Objective: To investigate the diagnostic value of the MDS research criteria for the detection of the prodromal phase of Parkinson’s disease (PD) in the general…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • 2024 International Congress

    Association of insomnia with levodopa-related parameters in Parkinson’s disease

    L. Atabekyan, N. Nadryan, E. Balian, H. Karkourian, H. Hovakimyan, Z. Tavadyan, S. Khachatryan (Yerevan, Armenia)

    Objective: With this analysis we aimed to study the role of insomnia (both sleep onset and sleep maintenance insomnias) in Parkinson’s disease (PD) in relation…
  • 2024 International Congress

    Modeling the Role of Parkinson’s Disease-Specific Factors in Depression and Anxiety: Findings from MEX-PD Cohort

    P. Reyes-Pérez, D. Martínez, I. Estrada-Bellmann, C. Guerra-Galicia, N. Gandarilla-Martínez, E. Morelos Figaredo, K. Salinas-Barboza, Y. Matuk-Pérez, A. Lazaro-Figueroa, M. Rentería, S. Alcauter-Solorzano, A. Ruiz-Contreras, A. Medina-Rivera (Queretaro, Mexico)

    Objective: This study, conducted within the Mexican Parkinson’s Disease Research Network (MEX-PD), aims to explore whether depression and anxiety in PD patients primarily stem from…
  • 2024 International Congress

    Predicting the Risk of Parkinson’s Disease by Body Composition and Metabolic Diseases in Gender and Age Dependent Manners

    J. Fu, H. Shang, X. Chen (Chengdu, Sichuan, China)

    Objective: Objective: This study intends to analyze the impact of body composition and metabolic diseases on the risk of Parkinson's disease (PD) using large-scale longitudinal…
  • 2024 International Congress

    Spectrum of Movement Disorders in Kazakhstan: Five Years of Insights from Kazakhstan’s First Movement Disorder Center

    ZH. Myrzayev, CH. Shashkin, G. Seidakhmetova, B. Abdenov, R. Kaiyrzhanov (Almaty, Kazakhstan)

    Objective: To describe the spectrum, demographics, and trends of movement disorders patients seen at the first movement disorder (MD) center in Kazakhstan over five years.To…
  • 2024 International Congress

    Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease

    K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell (Vancouver, Canada)

    Objective: ​​​To assess the feasibility of combining Mediterranean and ketogenic dietary principles in persons with Parkinson’s disease (PwP). Background: Dietary interventions have been proposed as…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley